Trademark Search in Canada

REMEXA

View On IC.GC.CA

REGISTERED

on 22 Feb 2024

Last Applicant/ Owned by

REPRESENTACIONES MEX-AMERICA, S.A. DE C.V.

DIAGONAL 20 DE NOVIEMBRE # 264COL. OBRERA06800Mexico City

Serial Number

1933636 filed on 3^rd Dec 2018

Registration Number

TMA1222663 registered on 22^nd Feb 2024

Registration expiry Date

22^nd Feb 2034

Correspondent Address

MILLER THOMSON LLP

40 KING STREET W., SUITE 6600, TORONTO,

ONTARIO

M5H3S1

REMEXA

Trademark usage description

hair protection creams, non-medicated; non-medicated aftershave creams; non-medicated body soaps; non-medicated cleansing creams for personal use; non Read More

Classification Information

Class [003]
Hair protection creams, non-medicated; non-medicated aftershave creams; non-medicated body soaps; non-medicated cleansing creams for personal use; non-medicated creams for facial scrubs; non-medicated creams for hydrating the skin; non-medicated creams for lightening the skin; non-medicated creams for moisturizing the skin; non-medicated creams for protection of the skin; non-medicated creams for softening the skin; non-medicated creams for soothing the skin; non-medicated creams for whitening the skin; non medicated diaper rash cream; non-medicated foot cream; non-medicated hand soaps; non-medicated liquid soaps; non-medicated scalp treatment cream; non-medicated skin creams; non-medicated soap for use on livestock; non-medicated soap for use on pets; non-medicated soaps for personal use; non-medicated soaps for the face; non-medicated soaps for the hands; non-medicated toilet soaps; skin care creams, non medicated;

Classification kind code

Class [005]
Anti-diabetic pharmaceuticals; antidiabetic pharmaceuticals; cardiovascular pharmaceuticals; CRISPR based pharmaceuticals for the treatment of genetic diseases; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; inhaled pharmaceutical preparations for treating respiratory diseases and disorders; injectable pharmaceutical contraceptives; injectable pharmaceuticals for treatment of anaphylactic reactions; neurological and psychological pharmaceutical preparations for the treatment of chemical dependency; neurological and psychological pharmaceutical preparations for the treatment of drug addictions; neurological and psychological pharmaceutical preparations for the treatment of eating disorders and addictions; opioid antagonist pharmaceutical preparations; pharmaceutical agents for treating physically caused lesions; pharmaceutical anti-allergic preparations and substances; pharmaceutical antiallergic preparations and substances; pharmaceutical antibody preparations for auto-immune diseases; pharmaceutical antibody preparations for respiratory disease; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical antitussive-cold preparations; pharmaceutical astringents; pharmaceutical cold preparations; pharmaceutical cough preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the prevention of diabetes; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of diabetes; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for controlling cholesterol; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for hydrating the skin during pregnancy; pharmaceutical preparations for inducing erections; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for maintaining normal blood pressure and heart function; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for preventing skin blemishes during pregnancy; pharmaceutical preparations for reducing cholesterol; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for suppressing tumours; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of iron deficiency and anaemia in humans; pharmaceutical preparations for the prevention and treatment of iron deficiency and anemia in humans; pharmaceutical preparations for the prevention and treatment of muscular atrophy; pharmaceutical preparations for the prevention and treatment of renal disease and disorders; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the prevention of stretch marks; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of pain; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for the treatment of acne; pharmaceutical preparations for the treatment of allergic rhinitis; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of blackheads; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the treatment of brain diseases and disorders, namely, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, multiple sclerosis; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of carpal tunnel syndrome; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of chronic liver diseases; pharmaceutical preparations for the treatment of chronic pain; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; pharmaceutical preparations for the treatment of cystic fibrosis; pharmaceutical preparations for the treatment of dandruff; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dental and oral diseases; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the spinal cord systems and related cartilage and tissue; pharmaceutical preparations for the treatment of drug and alcohol abuse; pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of gastro-intestinal diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of glaucoma; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of headaches; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of hepatological diseases and disorders; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for the treatment of hypercholesterolemia; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of mastitis; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of motion sickness; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of myalgia and neuralgia; pharmaceutical preparations for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis, Huntington's disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of physical and psychological addictions, namely, gambling addiction, eating disorders and addictions, nicotine addiction, Internet addiction, drug addiction; pharmaceutical preparations for the treatment of primary hyperoxaluria; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections; pharmaceutical preparations for the treatment of sexual dysfunction; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for the treatment of urovaginal infections; pharmaceutical preparations for the treatment of varicose veins; pharmaceutical preparations for the treatment of vascular diseases; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment of worms in pets; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating and preventing skin and nail diseases; pharmaceutical preparations for treating asthma; pharmaceutical preparations for treating cardiovascular diseases; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating digestive system disorders; pharmaceutical preparations for treating dry skin caused by pregnancy; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating halitosis; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating high cholesterol; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for treating hypoglycaemia; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating opioid overdoses; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating physically caused lesions; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for treating the symptoms of radiation sickness; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in discouraging the smoking habit; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for use in immunomodulation therapies; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in ocular disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in the treatment of autoinflammatory diseases; pharmaceutical preparations for use in the treatment of immunological disorders; pharmaceutical preparations for use in the treatment of musculoskeletal diseases; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of cancer; pharmaceutical products for treating respiratory diseases; pharmaceutical solutions used in dialysis; pharmaceuticals for ophthalmological use; pharmaceuticals for the prevention and treatment of cancer; pharmaceuticals for the treatment of bone diseases; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of coronavirus diseases and COVID-19; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals for treating respiratory diseases; pharmaceuticals for treating the symptoms of radiation sickness; radioactive pharmaceutical preparations for in vivo diagnostic or therapeutic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; transdermal pharmaceutical patches impregnated with insect repellent;

Classification kind code

Mark Details

Serial Number

1933636

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 23^rd Aug 2023	Registration Pending
Submitted for opposition 42 on 31^st May 2023	Advertised
Submitted for opposition 27 on 2^th May 2023	Approval Notice Sent
Submitted for opposition 26 on 2^th May 2023	Approved
Submitted for opposition 15 on 1^st Sept 2022	Correspondence Created
Submitted for opposition 22 on 13^th Oct 2021	Search Recorded
Submitted for opposition 20 on 13^th Oct 2021	Examiner's First Report
Submitted for opposition 31 on 5^th Dec 2018	Formalized
Submitted for opposition 30 on 3^rd Dec 2018	Filed
Submitted for opposition 1 on 3^rd Dec 2018	Created